Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool November 6, 2006 Jack Uldrich	TINY Investment Inches Closer to Payoff Carbon nanotubes move into semiconductor production fabs. Until more details are forthcoming, investors are cautioned against getting too excited.
Chemistry World June 5, 2012 Simon Perks	Chiral separation with micro-flows How do you separate enantiomers without any kind of chiral recognition between molecules? The answer it seems is to use asymmetric flow in a micro-fluidic channel.
The Motley Fool January 7, 2010 Brian Orelli	Pfizer Strides Farther Into Generics Pfizer's new look might be just what the doctor ordered.
The Motley Fool August 9, 2006 Jack Uldrich	A Tiny Nanotech IP Play Harris & Harris owns an equity stake in valuable nanotech intellectual property. Investors, take note.
The Motley Fool December 5, 2006 Jack Uldrich	A TINY Dose of Patience A lack of nanotech IPOs could hinder short-term returns for Harris & Harris. For all of nanotech's promise, investing in it remains a risky game.
Reactive Reports May 2007 David Bradley	Meeting of Molecular Movie Stars New footage confirms Linus Pauling's theory of chemical bonding proposed half a century ago, and could help explain molecular recognition processes important throughout supramolecular chemistry and molecular biology.
Chemistry World November 6, 2009 Phillip Broadwith	Enzyme binds both sides of the mirror European chemists have discovered that both mirror-image forms of a particular compound can bind at the same time in the same site of an enzyme, a phenomenon that has never been seen before.
The Motley Fool October 4, 2006 Jack Uldrich	TINY's Tiny Growth Engine Harris & Harris' investment in Cambrios could pay dividends over the long run.
The Motley Fool May 21, 2010 Brian Orelli	And You Thought Biotech Was High-Risk, High-Reward Large clinical trials make cardiovascular drugs risky, but the rewards are there, too.
Technology Research News November 5, 2003	Paired molecules store data Researchers from the University of California at Irvine have bonded a pair of molecules to form a molecule that has two states. The components are photochromic fulgimide and a dye molecule capable of florescence.
The Motley Fool November 30, 2010 Brian Orelli	A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist.
BusinessWeek November 29, 2004 Catherine Arnst	Big Pharma's Blinders Hugely profitable thanks to a few blockbusters, Big Pharma is far too focused on looking for the next best-seller, causing companies to pass up opportunities to deliver important breakthroughs.
The Motley Fool May 18, 2009 Brian Orelli	Free Drugs! Pfizer's giving over 70 drugs away -- to people who have lost their jobs and health insurance recently and can show financial hardship.
The Motley Fool February 25, 2004 Brian Gorman	Merck's Slow and Steady The big pharma's cautious approach could pay off in the industry.
Chemistry World May 18, 2011 James Urquhart	Throwing light on molecular logic gates The multifunctional molecule, which can be reconfigured by light, could be used in data storage devices and biomedicine, including nanoparticle tracking and drug delivery.
Technology Research News December 3, 2003	Molecule does two-step Duke University researchers have found a way to make a molecule react only when it has been hit by two photons of ultraviolet light, making the molecule a controllable switch. The molecule could eventually be used in optical storage devices and in biochips.
The Motley Fool December 21, 2010 Brian Orelli	4 Drugmakers, 5 Deals, Christmas Is Here It looks like there were a lot of people in the business development offices at pharmaceutical companies looking to get their work done before taking off for the holidays. Check out all the deals that were announced yesterday.
Chemistry World April 2011	Molecular Obesity is Weighing Down Drug Discovery Medicinal chemistry's quest for potent drug candidates has resulted in molecules that are too large and too lipophilic for their own good.
Technology Research News January 12, 2005	Branchy Molecules Make Precise Pores Researchers have found a way to coax a material containing microscopic pores to assemble from two very different types of molecules. The material could be used as packaging material for microscopic electronics, to store gases, and to deliver tiny amounts of drugs to very specific places.
Chemistry World May 15, 2012 Harriet Brewerton	Chiral Confusion Scientists in Israel have shown that non-biological chiral crystals are much more abundant than previously thought and their findings could clear up a possible confusion over the term 'chiral'.
Chemistry World March 11, 2010 Simon Hadlington	Thalidomide Binding Protein Revealed Scientists in Japan believe they have revealed one of the key molecular targets that binds to the drug thalidomide to cause birth defects.
The Motley Fool December 7, 2004 Wherrett & Yelovich	Lemons Ripen Faster Than Plums A venture capitalist in the nano sector is finding some nice pickings. However, valuing Harris is not an easy task, as the metrics of sales and profits are not relevant to a publicly traded VC company.
Chemistry World December 23, 2009 Phillip Broadwith	Opening the gate for molecular electronics Chemists in Korea and the US have shown that the current running through a transistor made of a single molecule can be regulated by tweaking its molecular orbital energies.
The Motley Fool July 10, 2007 Jack Uldrich	Welcome to My Tiny World Investors, in this interview, venture capitalist Charles Harris shows he knows his way around the high-risk, high-reward world of nanotechnology.
The Motley Fool September 22, 2005 Jack Uldrich	TINY Magnifies Its Hunt The nanotech venture capital firm announces its participation in two big nano private financings. Investors, take note.
Technology Research News September 10, 2003	Gold speck highlights molecules How do you sense what is happening at the scale of molecules? Researchers have found a way to detect the very small spectral shifts that occur when the light scattering off a single gold nanoparticle interacts with molecules.
The Motley Fool May 13, 2005 Jack Uldrich	TINY's Big Potential Harris & Harris' investments in Nanomix and other nanotech start-ups could lead to healthy returns.
Chemistry World November 3, 2011 Erica Wise	A Model for the Single Chirality of Life The boiling solutions in prebiotic hot springs could shed light on the emergence of a single chiral form of biomolecules in nature, say Spanish scientists.
Chemistry World September 6, 2013 Melissae Fellet	Unravelling stereochemistry via mass spectrometry Researchers have used mass spectrometry to determine the stereochemistry of a prototypical chiral molecule, CHBrClF.
The Motley Fool July 20, 2007 Jack Uldrich	A TINY Opportunity in Nanosys' News High-capacity flash-memory technology could be a boon to venture capital firm Harris & Harris.
Chemistry World March 8, 2011 Jon Cartwright	Carbon nanotubes - a boon for chiral catalysts Researchers in China have created a new catalyst that could help in the production of chiral molecules for medical drugs. The catalyst, which consists of platinum nanoparticles encapsulated in carbon nanotubes, is the most active of its type ever reported.
Chemistry World March 28, 2007 Victoria Gill	New Limits Set on Chirality Researchers have set a new standard in stereochemistry. Measuring Raman optical activity, they have confirmed the spatial arrangement of a molecule with almost impossibly subtle chirality: (R)-[ 2H 1, 2H 2, 2H 3]-neopentane.
The Motley Fool February 22, 2005 Charly Travers	Is Big Pharma a Bargain? While much of the drug sector is looking pretty tasty, Pfizer, with its attractive relative valuation, dominant marketing presence, and willingness to buy up blockbuster drugs, heads the list.
Technology Research News March 23, 2005	Nanowires track molecular activity Researchers from Harvard University have found a way to use transistors made from silicon nanowires to gain information about how small molecules bind to proteins.
Chemistry World February 12, 2014 Graham Wynne	Introduction to biological and small molecule drug research and development This text, edited by Ganellin and others, will be of particular interest both to the medicinal chemist who is looking to increase their knowledge beyond the small molecules area, and those with experience in the biologics field.
The Motley Fool May 12, 2005 Carl Wherrett	TINY's Tiny Decrease Smart investors should be looking at Harris & Harris' drop in net asset value due to a depreciation in the value of the 1.1 million shares still held by the VC company NeuroMetrix as an opportunity.
Chemistry World May 4, 2006 Katharine Sanderson	Cancer Charity Takes on Shelved Drugs Cancer Research UK, and its commercial arm, Cancer Research Technology have launched a clinical development partnership scheme to sweep up drug candidates that pharmaceuticals companies have deprioritized for not showing enough commercial promise.
The Motley Fool August 23, 2004 Ben McClure	Rethinking Big Pharma Risk is knocking Big Pharma stocks down. They won't be getting up anytime soon. Competition, soaring R&D costs, shifting business models, and political meddling combine to make drug stocks a riskier place to invest.
Chemistry World February 8, 2006 Jon Evans	To Boldly go Where no Chemist Has Gone Before Studying the interactions between different molecular fragments is taking researchers to the uncharted regions of chemical space.
Chemistry World April 29, 2009 James Urquhart	Huge pores in zeolite molecular sieve Researchers in Spain and Sweden have synthesized and structurally determined a new kind of crystalline molecular sieve with extra large holes and chiral properties.
Technology Research News June 30, 2004	Method tests molecular devices Components made from molecules are likely to be smaller than those that can be made using today's chip fabrication methods, and they can potentially self-assemble, which would make for inexpensive manufacturing processes.
The Motley Fool April 21, 2004 Ben McClure	Discount Pharmacy With prices beaten down across the pharmaceuticals industry and the quarterly reporting season here, do any investment opportunities pop up?
Chemistry World February 21, 2007 Tom Westgate	Complex Organic Molecules Teamed with Iodine Chemists have developed a method for constructing complex halogen-containing organic molecules from simple compounds in a single step. The discovery could pave the way for the synthesis of many potentially useful naturally occurring molecules.
The Motley Fool October 29, 2008 Tim Beyers	This Growth Stock Is Insanely Cheap Should you be buying Harris & Harris? This analyst has been, and so have insiders.
Chemistry World May 3, 2013 Alison Rodger	VCD spectroscopy for organic chemists I highly recommend VCD Spectroscopy, by Philip Stephens and others, for organic chemists as the textbook of choice on this useful topic.
Chemistry World April 28, 2009 Jon Cartwright	Metal ions give rise to threaded molecules Chemists in France have developed a simple method to synthesize tricky '[3]rotaxane' molecules for potential applications in intelligent materials and molecular machines.
The Motley Fool September 9, 2004 Charly Travers	The Case for Drug Stocks The reports of the drug industry's death are greatly exaggerated.
The Motley Fool February 3, 2010 Anders Bylund	Ride the Space Elevator to Riches! Harris & Harris and other nanotech specialists could ride their own space elevator in the next couple of years.
The Motley Fool September 26, 2007 Brian Orelli	4 Platform Drugmakers to Watch Platform drugmakers have the potential to develop multiple drugs for a company. Let's take a look at four companies with good prospects: Abraxis BioScience... DURECT... Halozyme... Flamel Technologies...
Technology Research News March 24, 2004 Eric Smalley	Molecular logic proposed Researchers from the French National Center for Scientific Research (CNRS) and University College London in England have devised a scheme for designing logic circuits within individual molecules.